Cyient DLM Limited has reported mixed Q4 results with a significant revenue decline offset by strong margin performance, prompting JPMorgan to maintain its positive outlook on the stock. The brokerage has assigned an Overweight rating with a target price of ₹400, citing expected recovery in FY27 despite near-term headwinds. The company's consolidated net profit surged significantly while revenue faced challenges during the quarter.

JPMorgan Analysis and Target Price

JPMorgan has maintained its Overweight rating on Cyient DLM with a target price of ₹400, highlighting the company's margin expansion trajectory and recovery prospects. The brokerage noted that Q4 results were mixed, with revenue missing expectations but margins beating forecasts for the third consecutive quarter. The analysis points to strong recovery expected in FY27 with approximately 20% growth as current headwinds fade.

Q4 Financial Performance

The company delivered contrasting performance in Q4, with robust profit growth demonstrating operational efficiency improvements despite revenue challenges. The financial metrics highlight the divergent trends in profitability and top-line performance:

Q4FY26 Earnings Call Recording Available

Cyient DLM Limited has made available the recording of its earnings conference call for Q4FY26, held on April 21, 2026, in compliance with Regulation 46 of SEBI LoDR Regulations 2015. The recording provides stakeholders with access to management discussions regarding the company's fourth quarter and year-end financial results:

FY26-FY27 Outlook and Growth Drivers

JPMorgan's analysis indicates that FY26 revenue decline will be impacted by the Bharat Electronics base effect, though this will be partially offset by the Altek acquisition. On an adjusted basis, the company is expected to achieve 4% growth in FY26. The brokerage anticipates a strong recovery in FY27 with approximately 20% growth as the current headwinds subside and the company's strategic initiatives gain momentum.

Strategic Growth Initiative

Cyient DLM has rolled out its comprehensive 'strengthen-expand-transform' strategy to capitalize on emerging market opportunities. The company is targeting multi-phase growth driven by increased defense spending, AI infrastructure boom, and global supply chain shifts. This strategic framework positions the company to leverage key growth sectors and expand its market presence through focused M&A initiatives in automotive, India defense, and Europe markets.

About Cyient DLM Limited

Established in 1993, Cyient DLM Limited is an integrated Electronics Manufacturing Solutions provider focusing on the entire product lifecycle including Design, Build and Maintain services. The company positions itself as one of the leading EMS companies in India, offering electronic solutions for safety and mission-critical applications in highly regulated industries.

Cyient DLM has received a neutral rating from Macquarie Group, with the brokerage house cutting its target price to ₹350 following the company's disappointing quarterly performance.

Quarterly Performance Challenges

The engineering and manufacturing services company significantly missed expectations during the quarter, with Macquarie attributing the underperformance to multiple external factors. The primary challenges identified include tariff-related issues and the ongoing conflict in West Asia, which have created operational headwinds for the company.

Order Book Strength vs Revenue Conversion

Despite maintaining a robust order book, Cyient DLM has struggled with revenue conversion during the reporting period. This disconnect between order strength and actual revenue generation has been a key concern highlighted by the brokerage in its assessment.

Management Outlook

The company's management has provided guidance suggesting a quarter-on-quarter revenue recovery in the upcoming period. This forward-looking statement indicates management's confidence in addressing current operational challenges and improving financial performance in subsequent quarters.

Brokerage Assessment

Macquarie's decision to maintain a neutral stance while reducing the target price reflects a cautious approach toward the stock. The brokerage appears to acknowledge both the near-term challenges faced by the company and the potential for recovery based on management guidance and the underlying strength of the order book.